
Ark Invest dropped $13M on Coinbase, Circle, and Bullish shares Monday. Circle also announced a BNY Mellon partnership for USDC custody. AlphaScala scores show mixed signals on the crypto names.
Cathie Wood's Ark Invest loaded up on Coinbase, Circle, and Bullish shares Monday, spending a combined $13 million across the three crypto-native names.
The purchases, disclosed in daily trade reports, landed across Ark's ARKK, ARKW, and ARKF funds. Coinbase got the biggest allocation: 45,164 shares worth $6.85 million at the close. Circle followed at 81,757 shares, or $6.21 million. Bullish, the digital asset exchange, got 149,422 shares, roughly $3.54 million.
Ark also added a sprinkling of Robinhood: 2,943 shares, about $300,000.
All four names ended Monday in the green. Coinbase closed up 1.74% at $151.65. Circle rose 3.25% to $75.96. Bullish added 1.72% to $23.69. Robinhood gained 3.18% to $101.83. The broader market also rallied – the S&P 500, Dow, and Nasdaq all finished higher.
Ark's portfolio guidelines cap any single holding at 10% of a fund's assets, which means the firm frequently rebalances after big price swings.
Monday came with a separate announcement from Circle: a closer partnership with Bank of New York Mellon. Under the arrangement, institutional clients can custody, transfer, mint, and redeem USDC stablecoins through BNY's digital wallet system.
Coinbase made its own news this month by launching tokenized U.S. equities on its platform, letting traders buy digital versions of traditional stocks. Benchmark Equity Research kept a “Buy” rating on Coinbase earlier in the month, with a $270 price target, citing the tokenized stock offering.
Ark's crypto buys were the most prominent part of Monday's trade list, not the only ones. The firm also picked up 68,906 shares of cloud infrastructure provider CoreWeave for $6.65 million, 138,735 shares of defense contractor Kratos at $6.55 million, and 136,406 shares of Generate Biomedicines for $2.25 million. It added 8,433 shares of Snowflake, worth $2.1 million.
On the sell side, Ark exited 47,874 shares of Twist Bioscience ($4.78 million), 127,305 shares of 10X Genomics ($4.67 million), and trimmed Alibaba by 9,272 shares ($879,078). It also sold 198,392 shares of Absci for $2.16 million.
The trades underscore Ark's conviction in crypto infrastructure names – Coinbase, Circle, Bullish – alongside a rotating basket of cloud and defense plays.
AlphaScala's data paints a mixed picture of the crypto-exposed names. COIN carries an Alpha Score of 20 out of 100, marked Weak. HOOD scores 35, classed Mixed. CRCL sits at 28, also Weak. None of the three are screaming value on the scoring model, Ark's Monday positioning suggests Wood sees something the scoreboard isn't yet capturing.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.